Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07715682

The Effect of Gentle Human Touch and Stimulus Reduction on Pain and Comfort During Heel Blood Collection in Premature Newborns

Premature infants frequently experience painful procedures during their admission to neonatal intensive care units; this can lead to acute adverse events, imbalances, and long-term neurodevelopmental implications. This randomized controlled trial evaluates the impact of Gentle Human Touch (GHT) and rate change (eye mask and earplug) on pain and comfort during heel prick blood collection in premature infants (32-36+6 weeks gestational age). A total of 60 infants were randomly assigned to three groups: GHT, rate change, and standard care (pacifier). Pain was assessed using the Premature Infant Pain Profile-Revised (PIPP-R), and comfort was measured before, during, and after the procedure using the COMFORTneo operator. Physiological impact (heart rate, oxygen saturation) and propagation time were recorded. The findings provide evidence for safe and effective non-pharmacological interventions in pain management and their inclusion in developmental care protocols.

Recruiting

Interested in participating?

Request Info

Key information

Age range

32 week–37 week

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Etlik City Hospital

Ankara, Turkey (Türkiye)

Location status: Recruiting

Location contact

Kübra S Kabakcı Sarıdağ

CONTACT

[email protected]

+90 5079149033

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Preterm infants with a gestational age between 32 and 36+6 weeks
  • Written informed consent obtained from parents

Exclusion criteria

  • Infants with serious medical conditions that may affect study parameters
  • Infants receiving intensive invasive treatments (e.g., opioid or sedative medication)

Treatment and study plan

gentle human touch

Other

Before starting the procedure, the nurse performing the intervention will wear a clean gown and wash both hands and forearms with an antimicrobial agent for 3 minutes.

The nurse's hand temperature will be measured with a digital thermometer prior to the intervention to ensure it is at an appropriate level. If the temperature is not suitable, both hands will be warmed under a radiant warmer until they reach 33-33.2 °C, and the intervention will begin once this temperature is achieved.

During the intervention, the nurse will place the fingertips of one hand on the infant's eyebrow line with the palm resting on the top of the head, while the other hand will be positioned on the lower abdomen covering the waist and hips, maintaining this position for 15 minutes.

Environmental Modification

Other

Infants assigned to the environmental modification group will receive an eye mask and neonatal earmuffs (Minimuffs) to reduce exposure to light and noise. The eye mask is a soft, adjustable, and disposable phototherapy band designed to block external light stimuli. The earmuffs are oval-shaped, foam-based neonatal ear protectors with hydrogel adhesive, designed to reduce noise levels by more than 50% and ensure safe single use. Both interventions will be applied 3-5 minutes before, during, and for 3-5 minutes after venous blood sampling, for a total of approximately 15 minutes. Standard care with a pacifier will also be provided according to unit practice.

Primary outcomes

  1. Procedural Pain Score

    Time frame: 5 minutes before the procedure, during the procedure, and 5 minutes after the procedure.

    The pain experienced during heel prick blood sampling will be assessed using the Premature Infant Pain Profile-Revised (PIPP-R) scale. The scale ranges from 0 to 21 (for premature infants), with higher scores indicating greater pain intensity.

  2. Procedural Comfort Score

    Time frame: 5 minutes before the procedure, during the procedure, and 5 minutes after the procedure.

    Comfort during heel prick blood sampling will be assessed using the COMFORTneo Scale. The scale ranges from 7 to 35, with higher scores indicating a lower level of comfort.

Secondary outcomes

  1. Crying Duration

    Time frame: During and immediately after heel prick blood sampling

    Total duration of crying during heel prick blood sampling will be measured with a stopwatch and recorded in seconds.

  2. Oxygen Saturation

    Time frame: 5 minutes before, during, and 5 minutes after heel prick blood sampling

    Oxygen saturation levels will be monitored with pulse oximetry.

Study contacts

Contact information is provided by the study sponsor or research team.

Kubra Nur N KABAKCI SARIDAĞ, RN, MSc

CONTACT

[email protected]

+905079149033

Sponsors and collaborators

Lead sponsor

Kubra Nur Kabakcı Sarıdağ

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 20, 2026
Registry last updated
Jul 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.